Adolescent Rhinoconjunctivitis Quality of Life Questionnaire (AdolRQLQ)

Juniper E

Distributed by Mapi Research Trust


Distributed by Mapi Research Trust

Basic description

The E-versions of this instrument are distributed by Mapi Research Trust


Juniper E

All of QOL Tech’s questionnaires are copyrighted. They may not be altered, sold, translated into another language or adapted for another medium (e.g., computer, internet) without Professor Elizabeth Juniper's permission through Mapi Research Trust
To measure the functional impairments that are most troublesome to patients between the ages of 12 and 17 years as a result of their rhinoconjunctivitis
Therapeutic area
  • Eye Diseases
  • Otorhinolaryngologic Diseases
  • Respiratory Tract Diseases
Therapeutic indication
  • Conjunctivitis
  • Rhinitis
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for North America
Bibliographic reference(s) of the original questionnaire

Contact and conditions of use


Juniper E

Contact information

Mapi Research Trust
27 rue de la Villette
69003 Lyon
Phone: +33 (0)4 72 13 66 66

Conditions of use

Paper versions

Specific conditions apply. Please contact QOL Technologies Ltd.


Electronic versions

Mapi Research Trust officially and exclusively distributes all electronic versions of the questionnaires developed by Professor E. Juniper and gives permission on behalf of QOL Technologies Ltd (QOL Tech).

A license agreement must be completed and a User fee is required to all users (commercial & academic users).

More information on QOL Tech’s electronic versions


Step-by-step process to obtain permission to use electronic versions of QOL Tech’s questionnaires

Step 1 - Firstly, QOL Technologies Ltd. (Mrs Jilly Styles - jill@qoltech.co.uk) has to be contacted in order to pay a standard one-off user fee calculated per language and per package of questionnaires (commonly called the “paper & .pdf versions”). This package includes the most frequently used versions of questionnaires, an implementation document which provides information on administration, analysis and interpretation, and some reprints that describe the development and validation of the questionnaires. Once this fee has been paid it entitles your organisation worldwide (study sponsor) to unlimited usage of the paper and .pdf versions of the questionnaire(s). 

This payment is required even if you intend using the questionnaires electronically.

Step 2 - Please fill out our user agreement and return it to us by e-mail. At this stage, though you are not required to sign the form, the information in the agreement is helping us calculate the quote (access fees) and determine the work that needs to be done with Mapi Language Services. We will be pleased to contact them on your behalf to obtain a quotation for the required work in case no electronic version is available in the language you are requesting and needs to be developed.

Step 3 - If you decide to go ahead, you will be requested to sign the full study-specific user agreement and return it completed to Mapi Research Trust (e-mail and hardcopy for our records). The invoice will then be issued.

Step 4 – If/When the version is available and once your payment has been received by Mapi Research Trust, you may use (depending on your request):

  1. The web-based version using the one-year access codes that will be sent to you shortly after
  2. The questionnaire(s) on the specified validated electronic device for the duration of your study.

If you have any question, please feel free to contact us, we will be happy to guide you through the process.

Access fees

Please consult our user agreement (Price and payment terms)

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Please contact QOL Technologies Ltd.


Original language(s)

  • English for North America


The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

AdolRQLQ - Paper version

Danish for Denmark*
Dutch for the Netherlands*
French for France*
German for Germany*
Hungarian for Hungary*
Romanian for Romania*
Russian for Ukraine*
Slovak for Slovakia*
Spanish for Spain*
Ukrainian for Ukraine*
* Performed by Mapi

For the most current list of languages available, please check: www.qoltech.co.uk

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Exclusive vendor for translation work: Mapi

Please contact QOL Tech for permission.

More information on translations

For information on, or permission to use the translations, please contact

Professor Elizabeth Juniper


Please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

A question? Contact us